Sahajanand Medical Technologies IPO
Sahajanand Medical Technologies Limited
Sahajanand Medical Technologies IPO Details
Sahajanand Medical Technologies Limited is coming up with an Initial Public Offering (IPO) of up to 27,644,231 equity shares, entirely through an Offer for Sale (OFS) by existing promoters and investors; no fresh equity will be issued.
The company, a leading manufacturer of interventional cardiovascular medical devices, will not receive any proceeds from the IPO as the funds will go to the selling shareholders including Shree Hari Trust, Samara Capital, Kotak Pre-IPO Fund, and NHPEA Sparkle Holding B.V.
The IPO will be a 100% Book Built Issue and the shares are proposed to be listed on both the BSE and NSE, with the price band and lot size to be announced before the issue opens.
SMT has reserved portions of the offer for Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and Eligible Employees, as per SEBI ICDR Regulations.
Sahajanand Medical Technologies IPO Strengths
- SMT is a well-established player in the interventional cardiovascular medical devices sector, especially in drug-eluting stents (DES), a high-margin product segment.
- Its in-house R&D is focused on developing next-generation technologies in vascular intervention, which positions SMT competitively in the med-tech space.
- Led by Bhargav Kotadia and Dhirajlal Kotadia, SMT benefits from experienced promoters who have deep domain expertise and a long-standing track record in the medical technologies industry.
- Presence of reputed private equity investors such as Samara Capital, Kotak Pre-IPO Fund, and NHPEA Sparkle Holding B.V., which indicates confidence in the company’s future growth potential.
Sahajanand Medical Technologies IPO Weaknesses
- The IPO is purely Offer for Sale (OFS) by existing shareholders; no funds are being raised for business expansion, which may not appeal to investors seeking capital utilization for growth.
- SMT operates in a highly competitive segment with global giants like Medtronic, Boston Scientific, Abbott, and domestic players like Meril Life Sciences.
- As a medical device manufacturer, SMT’s products are subject to rigorous regulatory approvals across geographies.
- A considerable portion of SMT’s revenue comes from exports to emerging markets. Currency fluctuations, geopolitical risks, and changing trade policies pose revenue risks.
- This being SMT’s first public issue, there is no prior market performance track record for its shares.
Sahajanand Medical Technologies Revenue & Profit
8.03 | +0.11 |
9.08 | -0.07 |
10.35 | +0.25 |
10
8
6
4
2
0
Sahajanand Medical Technologies IPO Dates
| Open Date | To be announced |
| Close Date | To be announced |
| Allotment Date | To be announced |
| Initiation of Refunds | To be announced |
| Credit of Shares to Demat Account | To be announced |
| Listing Date | To be announced |
Sahajanand Medical Technologies IPO Lot Size
| Minimum Lot Size | To be announced |
| Maximum Lot Size | To be announced |
Seize the Opportunity! Apply for Sahajanand Medical Technologies IPO
Free Demat Account Opening
Zero AMC Charges for First Year
Low DP Charges (Rs. 10 only)
Free IPO Report & Research
Sahajanand Medical Technologies IPO Subscription Breakup
| QIBs | To be announced |
| Non Institutional Investors | To be announced |
| Retail Investors | To be announced |
How to Apply for Sahajanand Medical Technologies IPO?
Step 1
First, you need to visit the IPO section on our website.
Step 2
Then, click on the 'IPO Listing' option to view the IPO.
Step 3
Open the Sahajanand Medical Technologies Limited IPO by tapping on it.
Step 4
You will see an option to subscribe that you need to click on.
Step 5
Now that you can see the IPO details, you must enter details like cut-off price, number of lots, and UPI ID.
Step 6
Next, verify your details and select the 'Subscribe' option to complete the bidding.
You have completed your bidding for the Sahajanand Medical Technologies Limited IPO. Log in and go to the 'IPO Transactions' section to track your allotment status.